Signal detection and analysis of sulfasalazine adverse reaction events based on the US FDA adverse event reporting database
Significant new AEs signals were observed in this study and may provide important support for clinical monitoring and risk identification in SSZ.
Authors
- Yi Du (ORCID: https://orcid.org/0000-0001-9568-0907)
- Chun Yang (ORCID: https://orcid.org/0000-0001-5813-0914)
- Ye Zheng (ORCID: https://orcid.org/0009-0005-8193-6939)
- Mengyi Hu (ORCID: https://orcid.org/0009-0003-6498-2883)
- Jiawen Luo (ORCID: https://orcid.org/0009-0005-0332-892X)
- Jinfeng Zhu (ORCID: https://orcid.org/0000-0002-1737-0185)
- Xiaochun Guo (ORCID: https://orcid.org/0009-0000-9602-3044)
- Liang Shi (ORCID: https://orcid.org/0009-0007-5164-1245)
- Yu‐Hong Chen (ORCID: https://orcid.org/0009-0009-8356-0153)
- Ziyi Luo (ORCID: https://orcid.org/0009-0009-8363-5581)
- Yin Huang (ORCID: https://orcid.org/0009-0005-6024-8491)
- Zhuoming Guo (ORCID: https://orcid.org/0009-0000-7061-1331)
- Yu Zeng (ORCID: https://orcid.org/0009-0000-0263-2990)
- Lingzhi Zhang (ORCID: https://orcid.org/0009-0005-0557-8789)
- Yi Liu (ORCID: https://orcid.org/0009-0003-6743-6415)
Institutions
- Guangdong Medical College (CN)
- Third Affiliated Hospital of Southern Medical University (CN)
- Dongguan People’s Hospital (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1080/14740338.2024.2438745
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.35